ARCHIVES

Breast Cancer Coalition Widens Its Agenda For Advocacy, Vows To Fight NIH Cutbacks

This article is from The Cancer Letter archive.

Vol. 21 No. 18 | May 5, 1995

Download PDF Visit The Full Archive

Related Articles

FDA Approves Avastin For Recurrent NSCLC

October 27, 2006

Advisors Reaffirm Survival As Standard For full FDA Approval Of Cancer Drugs

June 16, 1999

Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds

September 30, 2005

Merritt To Head Nursing Center’s Implementation; Nurse Research And Training Opportunities Varied

January 10, 1986

Endostatin Enters Phase II Trial For Neuroendocrine Tumors.

December 14, 2001

NCI Seeks Prevention Fellows.

March 9, 2001